← Alle mensen

SM

Sun Min Lim

4 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Subcutaneous versus intravenous amivantamab, both in combination with lazertinib, in refractory EGFR-mutated non-smal...

European journal of cancer (Oxford, England : 1990) · 9 september 2025

Neoadjuvant and Adjuvant Osimertinib in Stage IA to IIIA, EGFR-Mutant NSCLC (NORA).

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2025-05

Subcutaan versus IV amivantamab plus lazertinib bij EGFR-gemuteerd NSCLC: PALOMA-3

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 oktober 2024

Atezolizumab plus cabozantinib versus docetaxel bij gemetastaseerd NSCLC: CONTACT-01 fase III

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 juli 2024